EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter

Jacques Bouget iD, Frédéric Balusson iD, Pierre-Marie Roy iD, Damien Viglino iD, Laure Pavageau, Karine Lacut iD, Emmanuel Oger iD

Clinical Otolaryngology · 2023

DOI: 10.1111/coa.14040 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Clinical Otolaryngology, 2023. Verfasst von Jacques Bouget und 6 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES, Rennes, France. Hauptthemen laut MEDLINE: Epistaxis, Fibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: DGOS/French Ministry of Health, National Clinical Research Hospital Program (PHRC), Direction Générale de l’offre de Soins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To describe management, and to assess factors associated with antithrombotic prescription thereafter in patients who had epistaxis referred to emergency department (ED).

Design

Prospective cohort study. From EDs, clinical, biological and hospital data were collected. The clinical database was linked to the French Health Insurance Database where we retrieved antithrombotic drug deliveries in a 3‐month period before and after referral.

Setting

Multicentric population‐based cohort study within five well‐defined areas.

Participants

We considered 306 patients referred for epistaxis with a stable oral antithrombotic regimen before referral. Main Outcome Measures We considered management, hospital outcome and case fatality. Antithrombotic prescription in a 3‐month follow‐up period was categorised into three classes: no change, class change, or discontinuation. During follow‐up, hospitalisation for epistaxis or ischaemic events was searched.

Results

Among 306 adult individuals (mean age: 76 years), 166 took oral anticoagulant and 140 an antiplatelet drug. Blood transfusion was needed in 13.7% of patients and anterior packing alone in 61%. Half of the patients were hospitalised; 301 were discharged alive. Considering antithrombotic prescription thereafter we observed no change in 219 patients (72.8%), class changes in 47 patients (15.6%) and discontinuation in 35 patients (11.6%). We identified four independent predictors for antithrombotic prescription: hospitalisation (vs. returning home, p = .05), age ( p = .03), haemoglobin level ( p = .03) and oral anticoagulant (vs. antiplatelet agent, p < .001). During the 3 months following discharge, 2 thrombotic and 15 bleeding events were identified.

Conclusions

Epistaxis referred to emergency department had an impact on subsequent antithrombotic prescription. Clinical Trial Registration Clinical Trials.gov identifier: NCT02886533.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpistaxisFibrinolytic AgentsAdultAgedHumansAnticoagulantsCohort StudiesEmergency Service, HospitalPlatelet Aggregation InhibitorsProspective Studies

Stichwörter der Autor:innen

antithrombotic drugsemergencyepistaxismanagementmedication decision

Substanzen

AnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Univ Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES, Rennes, France.
  • Emergency Department, Rennes University Hospital, Rennes, France.
  • Emergency Department, Centre Hospitalier Universitaire, Institut MITOVASC, Université d'Angers, Angers, France.
  • F-CRIN INNOVTE, Paris, France.
  • Emergency Department, Grenoble-Alpes University Hospital, Grenoble, France.
  • Emergency Department, University hospital, Nantes, France.

ORCID-Profile: Jacques Bouget, Frédéric Balusson, Pierre-Marie Roy, Damien Viglino, Karine Lacut, Emmanuel Oger

Förderung

  • DGOS/French Ministry of Health
  • National Clinical Research Hospital Program (PHRC)
  • Direction Générale de l’offre de Soins

Zitieren

APA

Bouget, J., Balusson, F., Roy, P. M., Viglino, D., Pavageau, L., Lacut, K., & Oger, E. (2023). Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter. Clinical Otolaryngology. https://doi.org/10.1111/coa.14040

Vancouver

Bouget J, Balusson F, Roy PM, Viglino D, Pavageau L, Lacut K, et al. Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter. Clinical Otolaryngology. 2023. doi:10.1111/coa.14040

BibTeX
@article{Bouget2023,
  author = {Bouget, Jacques and Balusson, Frédéric and Roy, Pierre-Marie and Viglino, Damien and Pavageau, Laure and Lacut, Karine and Oger, Emmanuel},
  title = {Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter},
  journal = {Clinical Otolaryngology},
  year = {2023},
  doi = {10.1111/coa.14040}
}
Kostenlos starten →